31692643|t|Yokukansan, a Kampo medicine, enhances the level of neuronal lineage markers in differentiated P19 embryonic carcinoma cells.
31692643|a|Yokukansan (YKS), a traditional Japanese Kampo medicine, affects neurological and psychiatric disorders. It ameliorates hippocampal neurogenesis in animals. However, its effect on neuronal cell differentiation remains unclear. Therefore, we investigated the effects of YKS on pluripotent P19 embryonic carcinoma cells as neuronal differentiation model cells. Western blotting and immunocytochemistry revealed that 10 mug/mL YKS treatment during embryoid body formation or neuronal differentiation increased the expression of the neuronal stem cell marker, Nestin, by 1.9-fold and 1.7-fold, respectively, and of the mature neuron marker, NeuN, by 1.5-fold and 1.4-fold, respectively. We examined the effect of YKS on intracellular signaling pathways in P19 cells and found significant elevation in phospho-PDK1 and phospho-mTOR expression (1.1-fold and 1.2-fold, respectively). Therefore, we investigated the effect of PDK1 and mTOR inhibitors on the level of neuronal lineage markers. We found that the mTOR inhibitor significantly abolished the YKS effect on the level of neuronal lineage markers. Moreover, to identify the target(s) of YKS, antibody array analysis that simultaneously detects 16 phosphorylated proteins was performed. YKS significantly upregulated 10 phosphorylated proteins including PDK1, Akt, AMPK, PRAS40, mTOR, p70 S6 kinase, GSK-3alpha, Bad and ERK1/2 under cell proliferation conditions. These results suggest that YKS simultaneously activates multiple signaling pathways. Thus, we concluded that YKS enhances the level of neuronal lineage markers in differentiated P19 cells, however it does not induce neuronal differentiation. Furthermore, mTOR is the predominant mediator of the YKS effect on these cells.
31692643	0	10	Yokukansan	Disease	
31692643	95	98	P19	CellLine	CVCL:2153
31692643	99	118	embryonic carcinoma	Disease	MESH:D018236
31692643	126	136	Yokukansan	Disease	
31692643	138	141	YKS	Disease	
31692643	191	229	neurological and psychiatric disorders	Disease	MESH:D001523
31692643	395	398	YKS	Disease	
31692643	414	417	P19	CellLine	CVCL:2153
31692643	418	437	embryonic carcinoma	Disease	MESH:D018236
31692643	550	553	YKS	Disease	
31692643	763	767	NeuN	Gene	146713
31692643	835	838	YKS	Disease	
31692643	878	881	P19	CellLine	CVCL:2153
31692643	931	935	PDK1	Gene	5163
31692643	948	952	mTOR	Gene	2475
31692643	1044	1048	PDK1	Gene	5163
31692643	1053	1057	mTOR	Gene	2475
31692643	1129	1133	mTOR	Gene	2475
31692643	1172	1175	YKS	Disease	
31692643	1264	1267	YKS	Disease	
31692643	1363	1366	YKS	Disease	
31692643	1430	1434	PDK1	Gene	5163
31692643	1436	1439	Akt	Gene	207
31692643	1441	1445	AMPK	Gene	5562
31692643	1447	1453	PRAS40	Gene	84335
31692643	1455	1459	mTOR	Gene	2475
31692643	1476	1486	GSK-3alpha	Gene	2931
31692643	1496	1502	ERK1/2	Gene	5595;5594
31692643	1567	1570	YKS	Disease	
31692643	1649	1652	YKS	Disease	
31692643	1718	1721	P19	CellLine	CVCL:2153
31692643	1795	1799	mTOR	Gene	2475
31692643	1835	1838	YKS	Disease	

